Bloxazoc 25 mg tablete s produljenim oslobađanjem
| Name | Bloxazoc 25 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-302226345 |
| Active Substance | metoprololsukcinat |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 23,75 mg metoprololsukcinata što odgovara 25 mg metoprololtartarata |
| Pharmaceutical Form | tableta s produljenim oslobađanjem |
| Manufacturer | Krka d.d., Novo mesto, Novo Mesto, Slovenija TAD Pharma Gmbh, Cuxhaven, Njemačka |
| Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
| Marketing Authorisation Date | 03.08.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/20-02/08 |
| Registration Number | 381-12-01/38-20-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C07AB02 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
